Congenital disorder of glycosylation, type IIw: genes and variants
Explore variant evidence for Congenital disorder of glycosylation, type IIw across 3 analyzed proteins (SLC37A4, SLC35A2, CACNA1D). Linked ClinVar records include 8 pathogenic or likely pathogenic variants, 36 variants of uncertain significance and 2 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Congenital disorder of glycosylation, type IIw
SLC37A4: Glucose-6-phosphate exchanger SLC37A4
It transports glucose-6-phosphate into the endoplasmic reticulum so glucose-6-phosphatase can release free glucose during fasting. Biallelic loss-of-function variants cause glycogen storage disease type Ib, with fasting hypoglycemia, hepatomegaly, neutropenia, and inflammatory bowel disease.
6 ClinVar pathogenic / likely pathogenic and 38 uncertain variants in SLC37A4 have source records linked to Congenital disorder of glycosylation, type IIw. Association strength is not clinical gene validity.
SLC35A2: UDP-galactose translocator
It supplies UDP-galactose to the Golgi lumen for glycosylation of proteins and lipids. Germline loss-of-function variants cause a congenital disorder of glycosylation, while somatic mosaic brain variants are associated with cortical malformations and epilepsy.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SLC35A2 have source records linked to Congenital disorder of glycosylation, type IIw. Association strength is not clinical gene validity.
CACNA1D: Voltage-dependent L-type calcium channel subunit alpha-1D
It supports calcium entry in endocrine cells, neurons, and cardiac pacemaker tissue, influencing hormone secretion, neuronal excitability, and sinoatrial activity. Activating variants can cause primary aldosteronism with seizures and neurologic abnormalities, while other variants cause neurodevelopmental or hearing phenotypes.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CACNA1D have source records linked to Congenital disorder of glycosylation, type IIw. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Congenital disorder of glycosylation, type IIw
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SLC37A4 C183R | 183 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC37A4 R300H | 300 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC37A4 G339D | 339 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC37A4 G20D | 20 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC37A4 R28H | 28 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC37A4 G150R | 150 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC35A2 E103V | 103 | Transmembrane | Pathogenic / likely pathogenic (★) |
| CACNA1D F747L | 747 | II | Pathogenic / likely pathogenic |
Which prediction tools work for Congenital disorder of glycosylation, type IIw
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 96 out of 100
- ESM1b (LLR): 96 out of 100
- CATVariant: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Glycogen storage disease also has ClinVar records linked to SLC37A4 variants; they fall mostly in different places as the Congenital disorder of glycosylation, type IIw variants (30 pathogenic / likely pathogenic).
- SLC35A2-congenital disorder of glycosylation also has ClinVar records linked to SLC35A2 variants; they fall mostly in different places as the Congenital disorder of glycosylation, type IIw variants (12 pathogenic / likely pathogenic).
Diseases related to Congenital disorder of glycosylation, type IIw
- Glycogen storage disease, also linked to SLC37A4
- Diabetes mellitus, also linked to CACNA1D
- Epilepsy, also linked to CACNA1D
- SLC35A2-congenital disorder of glycosylation, also linked to SLC35A2
- Phosphate transport defect, also linked to SLC37A4
- Myocardial infarction, also linked to CACNA1D
- Aldosterone-producing adenoma with seizures and neurological abnormalities, also linked to CACNA1D
- Sinoatrial node dysfunction and deafness, also linked to CACNA1D
Frequently asked questions
Which genes have records linked to Congenital disorder of glycosylation, type IIw?
This view contains 3 analyzed proteins: SLC37A4, SLC35A2, CACNA1D. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 8 pathogenic or likely pathogenic variants, 36 variants of uncertain significance and 2 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 50 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center